On October 12, 2026, Tenaya Therapeutics is trading 5.17% lower at $0.55; no verified company-specific catalyst explaining the decline has been identified.

  • The recent MyPEAK-1 item is a planned update, not a reported new result.
  • The broader market is nearly flat and does not clearly explain the stock-specific drop.
  • The supplied price context includes no volume or activity data.